Maitreya Medicare Ltd vs Molbio Diagnostics Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Maitreya Medicare Ltd is ₹ 144.55 as of 23 Oct 15:30 . The P/E Ratio of Maitreya Medicare Ltd changed from 30.8 on March 2024 to 0 on March 2026 . This represents a CAGR of -100.00% over 3 yearsThe P/E Ratio of Molbio Diagnostics Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Maitreya Medicare Ltd changed from ₹ 80.63 crore on March 2024 to ₹ 121.19 crore on March 2026 . This represents a CAGR of 14.55% over 3 yearsThe Market Cap of Molbio Diagnostics Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The Revenue of Maitreya Medicare Ltd is ₹ 0 crore as of Jun '25 .The Revenue of Molbio Diagnostics Ltd is ₹ 100.47 crore as of Jun '25 . The EBITDA of Maitreya Medicare Ltd is ₹ 0 crore as of Jun '25 .The EBITDA of Molbio Diagnostics Ltd is ₹ -15.35 crore as of Jun '25 . The Net Profit of Maitreya Medicare Ltd is ₹ 0 crore as of Jun '25 .The Net Profit of Molbio Diagnostics Ltd is ₹ -23.94 crore as of Jun '25 . The Dividend Payout of Maitreya Medicare Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Molbio Diagnostics Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Maitreya Medicare Ltd

Maitreya Medicare Limited was originally incorporated as Maitreya Medicare Private Limited' at Surat Gujarat, vide a Certificate of Incorporation dated March 28, 2019, issued by the Registrar of Companies, Central Registration Centre (CRC).
Thereafter, name of the Company was changed to Maitreya Medicare Limited' and a fresh Certificate of Incorporation was issued by the RoC on March 30, 2023.
Since then, Company engages in providing healthcare services and products. The Company was founded by Dr. Narendra Singh Tanwar, an eminent and highly skilled cardiologist who has more than 20 years of experience in healthcare industry.
The Company is a growing organization that aims at strengthening and establishing itself as foremost healthcare services provider.
It has a team of medical practitioners who ensures that patients get the quality healthcare services.

About Molbio Diagnostics Ltd

Molbio Diagnostics Limited was originally incorporated as Molbio Diagnostics Private Limited' at Panaji, as a private company dated October 20, 2000.
Thereafter, Company was converted from a private limited company to a public limited company, and the name of Company was changed to Molbio Diagnostics Limited, and a fresh certificate of incorporation dated January 16, 2025 was issued to Company by the RoC. Company is innovative point-of-care (POC) diagnostics company focused on expanding access to accurate, rapid and cost-effective healthcare technologies to diagnose infectious and non-communicable diseases.
The Company entered into a joint venture agreement in August, 2011 with Bigtec Innovations Private Limited and Bigtec Private Limited, which started operations in 2000.
Bigtec Innovations Private Limited got merged with the Company in 2015.

FAQs for the comparison of Maitreya Medicare Ltd and null

Which company has a larger market capitalization, Maitreya Medicare Ltd or Molbio Diagnostics Ltd?

Market cap of Maitreya Medicare Ltd is 97 Cr while Market cap of Molbio Diagnostics Ltd is 14,262 Cr

What are the key factors driving the stock performance of Maitreya Medicare Ltd and Molbio Diagnostics Ltd?

The stock performance of Maitreya Medicare Ltd and Molbio Diagnostics Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Maitreya Medicare Ltd and Molbio Diagnostics Ltd?

As of October 25, 2026, the Maitreya Medicare Ltd stock price is INR ₹144.55. On the other hand, Molbio Diagnostics Ltd stock price is INR ₹1237.65.

How do dividend payouts of Maitreya Medicare Ltd and Molbio Diagnostics Ltd compare?

To compare the dividend payouts of Maitreya Medicare Ltd and Molbio Diagnostics Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.